Log in to search using one of your social media accounts:

 

Atorvastatin Treatment and Risk of Diabetic Foot Infection Atorvastatin Treatment and Risk of Diabetic Foot Infection
Previous atorvastatin use may help protect against the development of diabetic foot infection among adult patients with diabetes, a new study reports.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Does Lipitor Help Rheumatoid Arthritis?
Title: Does Lipitor Help Rheumatoid Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 8/15/2017 12:00:00 AMLast Editorial Review: 8/15/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 15, 2017 Category: Rheumatology Source Type: news

Give chronic kidney disease patients a statin, doctors urged
20 mg of atorvastatin will help curb their risk of cardiovascular disease, says NICE Related items fromOnMedica Taking statins linked to improved heart structure and function Statins' side effects have been overstated, study suggests Salt intake linked to CVD risk in kidney patients Diet for lowering blood pressure also reduces risk of kidney disease Kidney cancer drug approved for NHS use (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 27, 2017 Category: UK Health Source Type: news

Is Lipitor Safe if I Have Fatty Liver?
Title: Is Lipitor Safe if I Have Fatty Liver?Category: Doctor's& Expert's views on SymptomsCreated: 6/29/2017 12:00:00 AMLast Editorial Review: 6/29/2017 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - June 29, 2017 Category: Cardiology Source Type: news

Statins side effects 'have been overstated', says study
Conclusion This is a complex study that provides a plausible explanation for the difference in reports of adverse effects of statins in RCTs and observational studies, some of which have suggested as many as 1 in 5 people get side effects from statins. However, we need to be aware of some limitations and unanswered questions: When people knew they were taking statins, they were more likely to report muscle pain than those not taking statins. But they were less likely to report muscle pain than in the first phase of the study, when they didn't know whether they were taking statins or placebo. We don't know why this is. ...
Source: NHS News Feed - May 3, 2017 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

Statins side effects 'have been overstated,' says study
Conclusion This is a complex study that provides a plausible explanation for the difference in reports of adverse effects of statins in RCTs and observational studies, some of which have suggested as many as 1 in 5 people get side effects from statins. However, we need to be aware of some limitations and unanswered questions: When people knew they were taking statins, they were more likely to report muscle pain than those not taking statins. But they were less likely to report muscle pain than in the first phase of the study, when they didn't know whether they were taking statins or placebo. We don't know why this is. ...
Source: NHS News Feed - May 3, 2017 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

' Suggestion' of Brain Changes on Statins by fMRI in STOMP'Suggestion' of Brain Changes on Statins by fMRI in STOMP
Despite few differences at cognitive testing for patients on atorvastatin vs placebo in the STOMP substudy,"small but significant" neuronal changes were seen on statins, their meaning unclear.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

New drug shows promise in preventing heart attacks
Conclusion This is a high-quality, well-conducted randomised controlled trial conducted in a very large number of people across multiple countries. To date, it's remained uncertain whether evolocumab reduces the risk of cardiovascular events. This study provides good evidence that the drug reduces the risk of major cardiovascular events in people with high LDL cholesterol levels, and with a high risk of having a cardiovascular event, who are already taking statins. The follow-up is limited to around two years, during which roughly 1 in 10 people experienced a cardiovascular event. The reduction in risk was shown to inc...
Source: NHS News Feed - March 20, 2017 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

atorvastatin (Lipitor) vs. simvastatin (Zocor)
Title: atorvastatin (Lipitor) vs. simvastatin (Zocor)Category: MedicationsCreated: 3/2/2017 12:00:00 AMLast Editorial Review: 3/2/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 2, 2017 Category: Cardiology Source Type: news

Caduet (Amlodipine Besylate, Atorvastatin Calcium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 9, 2017 Category: Drugs & Pharmacology Source Type: news

Health Care Special Report: KU doc finds cancer hope
After years of treating patients, researching cancer and testing treatments, Tomoo Iwakuma made the discovery of his lifetime: Statins, typically used to lower cholesterol levels, could treat some types of cancer. An associate professor at the University of Kansas Medical Center, Iwakuma thinks that statins — such as brand names Crestor and Lipitor — could be used to treat 10 to 20 percent of cancer patients with a mutation in a tumor suppressor protein called p53. This mutation is found in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Make the Diagnosis: Guess the Vessel
(MedPage Today) -- Case Findings: A 50-year old male with family history significant for premature CAD presents with chest pain which started 3 hours ago. Blood pressure 150/90 mm Hg, HR 60/min. EKG in the emergency department is shown (see image below). Successful intervention of the culprit coronary artery is performed with one drug eluting stent. He is started on aspirin, ticagrelor, atorvastatin and metoprolol. Next morning he is found to be hypotensive to SBP 90s. Hemoglobin, creatinine and electrolytes are normal. Right groin access site is without any hematoma. A stat bedside echocardiogram reveals ejection fraction...
Source: MedPage Today Cardiovascular - January 30, 2017 Category: Cardiology Source Type: news

Liptruzet (Ezetimibe and Atorvastatin Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news

Lipitor (atorvastatin)
Title: Lipitor (atorvastatin)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/1/2016 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - November 1, 2016 Category: Cardiology Source Type: news

Lipitor (Atorvastatin Calcium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 27, 2016 Category: Drugs & Pharmacology Source Type: news

Amgen cholesterol drug reduces arterial plaque buildup: study
(Reuters) - Amgen Inc said on Tuesday its potent new cholesterol fighter, Repatha, met the primary and secondary goals of a study designed to show it can decrease plaque buildup in heart arteries of patients already taking widely used statin drugs, such as Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - September 20, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Can social media data lead to earlier detection of drug-related adverse events? - Duh MS, Cremieux P, Audenrode MV, Vekeman F, Karner P, Zhang H, Greenberg P.
PURPOSE: To compare the patient characteristics and the inter-temporal reporting patterns of adverse events (AEs) for atorvastatin (Lipitor( ®) ) and sibutramine (Meridia(®) ) in social media (AskaPatient.com) versus the FDA Adverse Event Reporting System... (Source: SafetyLit)
Source: SafetyLit - September 9, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Statins are 'safe, effective and should be used more widely'
Conclusion This study reviews evidence from randomised controlled trials (RCTs) and observational studies to better evaluate the effects and safety of statin therapy. It provides valuable data on the size of the benefits compared with the risks, informing a topic that has had much media coverage in recent times. The researchers highlight that the benefits of statin therapy for people at risk of cardiovascular disease events far outweigh any possible side effects. But it is still for a doctor and their patient to come to a conclusion about what the best treatment for them may be. If you have been prescribed a statin, it...
Source: NHS News Feed - September 9, 2016 Category: Consumer Health News Tags: QA articles Medication Heart/lungs Source Type: news

Atorvastatin Improves Arterial Stiffness in SLE (CME/CE)
(MedPage Today) -- Potential to reduce subclinical atherosclerosis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 18, 2016 Category: Cardiology Source Type: news

Make the Diagnosis: Dizziness Dilemma
(MedPage Today) -- Case Findings: A 42-year-old African American male presents with a report of dizziness and lightheadedness 3 days ago when he was standing up to go to the rest room. He denies any syncopal episodes. He has medically managed hypertension, hypercholesterolemia, and cardiomyopathy, and a last ejection fraction of 35% with defibrillator placement 4 months ago. His AICD did not fire during the dizziness episode. His last cardiac catheterization prior to AICD implantation revealed normal coronaries. The patient has been compliant with metoprolol 25 mg twice daily, lisinopril 10 mg daily, atorvastatin 40 mg dai...
Source: MedPage Today Cardiovascular - August 10, 2016 Category: Cardiology Source Type: news

Buying into generic drugs
It is amazing how something so small can cost so much. Whether it is a short-term treatment, or multiple drugs you take indefinitely, prescription drugs have the potential to drain your savings. However, there are many cheaper generic versions of more expensive brand-name drugs. In fact, almost 80% of prescriptions are for generic drugs, according to the Food and Drug Administration (FDA), and on average they cost about 80% to 85% less than brand names. Odds are there is generic version to treat your condition, too, whether it is chronic pain, high cholesterol, high blood pressure, diabetes, asthma, or depression. But is t...
Source: New Harvard Health Information - July 15, 2016 Category: Consumer Health News Authors: Matthew Solan Tags: Drugs and Supplements Health care Managing your health care Source Type: news

Navigating Your Medications: Five Questions To Ask Your Pharmacist Or Doctor
Mrs. T, age 79, suffers from diabetes and hypertension, among other conditions. Like about one in three older Americans, she takes more than five medications on a regular basis--in her case, nine. On a recent phone call with Nurse Alicia Schwartz, Mrs. T mentioned taking a medication that her nurse knew was no longer among those prescribed for her. "I wasn't feeling well, and this helped me before," Mrs. T. said. Alicia explained that the doctor had replaced the discontinued medicine with another prescription that addresses a similar condition, and the two together can cause dizziness and a severe drop in blood...
Source: Healthy Living - The Huffington Post - June 22, 2016 Category: Consumer Health News Source Type: news

Meet The Woman Who Launched A New Field Of Scientific Study
As a female chemical engineer, Frances Arnold was already a rarity. After all, only about 16 percent of chemical engineers are women. But now that she has become the first woman ever to win the prestigious Millennium Technology Prize — it was awarded in Helsinki, Finland, on May 24 — Arnold is truly one of a kind. And she knows that in addition to a big cash award (1 million euros, or about $1.3 million), the prize brings an opportunity to spotlight the gender gap in STEM (science, technology, engineering and math) careers and to be a role model for other women. "I hope that my getting this prize will high...
Source: Science - The Huffington Post - May 31, 2016 Category: Science Source Type: news

CardioBrief: Rosuvastatin Goes Generic, Major Role Expected
(MedPage Today) -- Finally there's a challenger to the long reign of atorvastatin, experts say (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 2, 2016 Category: American Health Source Type: news

Make the Diagnosis: Dizziness Dilemma
(MedPage Today) -- Case Findings: The patient is a 42-year-old African American man who presents with a complaint of dizziness lightheadedness which occurred when he was standing up to go to the rest room 3 days ago. He denies any previous syncopal episodes. He has medically managed hypertension, hypercholesterolemia, cardiomyopathy with last ejection fraction of 35% with defibrillator placement 4 months previous. His ICD did not fire during the episode. His last cardiac catheterization prior to ICD implantation revealed normal coronaries. Patient has been compliant with metoprolol 25 mg twice daily, lisinopril 10 mg daily...
Source: MedPage Today Endocrinology - April 26, 2016 Category: Endocrinology Source Type: news

Your New Toolkit for Patient-Centric Change
Repeating the same action and expecting different results is the definition of insanity. That is the simple rationale for why we need new design tactics to deliver on the promise of patient centricity; reaching for the same tired approaches won’t deliver different outcomes. While it can be hard to find inspiration, we hope to tackle that with the eyeforpharma Philadelphia awards. In addition to simply recognizing good work, we want to encourage the spread of good ideas that could benefit us all. Check out these three strategies deployed by the ‘Most Valuable Patient Initiative or Service’ finalists. Work ...
Source: EyeForPharma - April 15, 2016 Category: Pharmaceuticals Authors: Thomas Disley Source Type: news

New drug 'effective' for those with intolerable statin side effects
Conclusion The main results of this study relate to the lipid-lowering effects of two alternative non-statin medications. However, it highlights the muscle-related adverse effects that can occur with statins. The study is carefully designed and has many strengths, including: a washout period between drugs to remove any residual effects double-blind design throughout so people didn't know what they were taking sufficient duration for each phase of the study (10 and 24 weeks) to allow effects to develop a good sample size – the researchers calculated beforehand how many people would need to be recruited to...
Source: NHS News Feed - April 4, 2016 Category: Consumer Health News Tags: Heart/lungs Medication Older people Source Type: news

Statin intolerance is real, researchers find. Another (more costly) drug may get around the problem.
Statins like Lipitor and its generics have revolutionized cardiovascular care for nearly two decades as an effective, inexpensive way to reduce LDL cholesterol, the so-called bad cholesterol in the bloodstream. Not everyone can take them, though; a significant number of people complain of muscle pain, weakness and cramping so severe that they discontinue the therapy […] (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 3, 2016 Category: Consumer Health News Authors: Lenny Bernstein Tags: prescription drugs health newsletter Source Type: news

Some People Really Can't Take Statins For High Cholesterol, Scientists Prove
You can't write a story about the lifesaving benefits of the cholesterol-lowering drugs called statins without getting comments like this one, from reader Bill Hayman, on my story yesterday: I cannot take Crestor or Zetia or any form of statin drug! I can barely walk with any statin drug. My legs become painful and so weak, they feel like rubber. Several years ago, I used Lipitor and had four pancreatic attacks until I stopped the Lipitor. Or this, from reader James Leedy: People should be warned of side effects. Doctors should listen to patients . I have taken statins for several years. I had extreme muscle pains all t...
Source: Forbes.com Healthcare News - April 3, 2016 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Statin intolerance objectively identified in patients
(Cleveland Clinic) In the first major trial of its kind, Cleveland Clinic researchers used a blinded rechallenge with atorvastatin or placebo to objectively confirm the presence of muscle-related symptoms in patients with a history of intolerance to multiple statins and found that evolocumab (a PCSK9 inhibitor) was a more effective option to lower cholesterol than ezetimibe in these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 3, 2016 Category: Global & Universal Source Type: news

Drug company victim of pre-April Fool's Day hoax
One of the country's largest pharmaceutical companies was the victim of a hoax in the form of a phony press release. Pfizer Inc., the maker of drug products including Lipitor and Viagra, said a false press release related to drug pricing and linking to a fake Web site was anonymously issued Thursday. The fake release "announced" Pfizer (NYSE: PFE) would "cease routine price increases" and cut some drug prices to improve access. The fake Web site is no longer operational. The New York City-based… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 1, 2016 Category: Biotechnology Authors: John George Source Type: news

Drug company victim of pre-April Fool's Day hoax
One of the country's largest pharmaceutical companies, which has ties to the Philadelphia region, was the victim of a hoax in the form of a phony press release. Pfizer Inc., the maker of drug products including Lipitor and Viagra, said a false press release related to drug pricing and linking to a fake Web site was anonymously issued Thursday. The fake release "announced" Pfizer (NYSE: PFE) would "cease routine price increases" and cut some drug prices to improve access. The fake Web site is no… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 1, 2016 Category: Pharmaceuticals Authors: John George Source Type: news

atorvastatin, Lipitor
Title: atorvastatin, LipitorCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 3/30/2016 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - March 30, 2016 Category: Cardiology Source Type: news

Statin drugs increase risk for diabetes and weight gain
(NaturalNews) Pfizer's Lipitor (atorvastatin) is a record-breaking drug, a prescription with the highest peak sales of any drug on the market. Statin drugs like this one, along with other brand equivalents and generics, are a medical doctor's go-to "solution" for managing patient's... (Source: NaturalNews.com)
Source: NaturalNews.com - March 14, 2016 Category: Consumer Health News Source Type: news

Atorvastatin: A Drusen Disintegrator?Atorvastatin: A Drusen Disintegrator?
Can treatment with a high-dose statin for age-related macular degeneration resolve drusen and improve visual acuity? Medscape Optometry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2016 Category: Consumer Health News Tags: Viewpoint Source Type: news

Studying for USMLE Step 2? Master this most missed question
Studying for the United States Medical Licensing Examination® (USMLE®) Step 2 may seem daunting, but not to fear. Starting this month, we’re giving you an exclusive scoop on the most missed USMLE Step 2 test prep questions and expert strategies to help you beat them. Check out this month’s most challenging question, and view an expert video explanation of the answer from Kaplan Medical. Welcome to the first Step 2 post in AMA Wire’s® series, “Tutor talk: Tips from Kaplan Medical on the most missed USMLE test prep questions from Kaplan’s Qbank.” Each month, we’re ...
Source: AMA Wire - February 24, 2016 Category: Journals (General) Authors: Amy Farouk Source Type: news

Could statins treat common cause of vision loss?
ConclusionThe difference between the dramatic improvement seen in the case study of the 63-year-old man and the comparatively modest, or lack of, effect seen in the 23 taking part in the trial shows the limitations of studying small numbers of people, and the current uncertainly about the effects of this treatment. There is large variability in small groups, which doesn't tell us whether the treatment will help most people. The way to solve this is to study lots more people. This helps to smooth out the natural variability in people's responses to the same treatment and can highlight groups more or less likely to benefit. ...
Source: NHS News Feed - February 5, 2016 Category: Consumer Health News Tags: Older people Medication Source Type: news

STATINS found to clear away deposits that cause blindness in the elderly
High-dose treatment with the statin Lipitor cleared away fatty deposits behind the retina, leading to visual improvement in patients with age-related macular degeneration (AMD), say Harvard researchers. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2016 Category: Consumer Health News Source Type: news

The Jekyll and Hyde of Statins
By Drs. David Niesel and Norbert Herzog, Medical Discovery News Cholesterol-lowering drugs called statins are the most prescribed drug ever. About 30 percent of Americans are currently taking statins such as Crestor, Lipitor, Mevacor and Zocor. Overall, statins can be good thing, but as with all drugs, there are some negative effects. Statins lower cholesterol by inhibiting a protein called HMG-CoA reductase. Since high cholesterol levels are linked to heart disease, statins can reduce the risks of heart attack and stroke, two of the leading causes of death in the United States. Recent reports from the American Heart Assoc...
Source: Science - The Huffington Post - February 3, 2016 Category: Science Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Patient Care - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

Identifying Acute STEMI in the Presence of Paced Rhythm
EMS responds to a local coffee shop for a 77-year-old male who has reportedly fainted. While en route the call is upgraded to an unconscious patient and an engine company is dispatched for backup. On arrival the patient is conscious but lethargic. He appears acutely ill. The skin is pale and diaphoretic. His past medical history includes hypertension, dyslipidemia, myocardial infarction, a coronary artery bypass graft and heart failure. His current medications are aspirin, metoprolol, atorvastatin, lisinopril and furosemide. Upon further questioning he admits to chest discomfort. His OPQRST assessment is as follows: ≫ On...
Source: JEMS Special Topics - January 18, 2016 Category: Emergency Medicine Authors: Tom Bouthillet, NREMT-P Tags: Case of the Month Special Topics Cardiac & Resuscitation Patient Care Source Type: news

The Biggest Medical Stories You May Have Missed In 2015
SPECIAL FROM Next Avenue By Craig Bowron As we head into the New Year, let’s take a look back and see what lessons we should have learned from medical science in 2015. The New England Journal of Medicine’s publication Journal Watch provides physicians and other health care providers with expert analysis of the most recent medical research. Below is a brief synopsis of what the Journal Watch editors felt were the most important stories in general medicine for the year 2015. While you likely heard about a couple, others probably escaped your radar. Getting Aggressive with Strokes We’re familiar with the id...
Source: Science - The Huffington Post - January 15, 2016 Category: Science Source Type: news

Brent Saunders Softens His View On Research With Jim Cramer On 'Mad Money'
Drug discovery is a key component of R&D and Pfizer has a long history of discovering major new medicines, including drugs like Zoloft, Zithromax, Lipitor and, yes, Viagra. However, Saunders has made his reputation on repudiating the need for such investments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2015 Category: Pharmaceuticals Authors: John LaMattina Source Type: news

Pfizer-Allergan deal a prelude to splitting company
(Reuters) — A Pfizer (NYSE:PFE) merger with Ireland-based Allergan (NYSE: AGN), in addition to providing tax benefits, would bolster the U.S. drugmaker’s growth prospects should it decide to sell or spin off its portfolio of products that have gone off patent. Many Wall Street analysts believe Pfizer will decide to split late next year, after compiling 3 years of financial data treating its “established products” division, which sells generic medicines, and its “innovative” patent-protected medicines unit, as if they were separate companies. Such a split would dramatically boos...
Source: Mass Device - November 6, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Pharmaceuticals Allergan Inc. Pfizer Inc. Source Type: news

Heart Disease and Diabetes Trials Anticipated at Kidney WeekHeart Disease and Diabetes Trials Anticipated at Kidney Week
New data will be presented on empagliflozin in patients with diabetes, and results from trials of atorvastatin and kidney injury after cardiac surgery will be released. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 29, 2015 Category: Consumer Health News Tags: Nephrology News Source Type: news

Impact of Dual Lipid-Lowering on Coronary PlaqueImpact of Dual Lipid-Lowering on Coronary Plaque
Find out how ezetimibe and atorvastatin combined impact coronary atherosclerosis in patients undergoing PCI. Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2015 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dr Reddy's recalls over 55K bottles of hypertension drug in US
Dr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 4, 2015 Category: Pharmaceuticals Source Type: news

FTC clears Pfizer’s $15B Hospira buy
Pfizer (NYSE:PFE) said Monday it won approval from the Federal Trade Commission for its $15 billion acquisition of Hospira (NYSE:HSP). The clearance came with a caveat –Pfizer must divest itself of its Acetylcysteine, Clindamycin, Voriconazole and Melphalan sterile injectable assets, according to the company. The news from the FTC came August 21, according to an SEC filing from Hospira, and leaves the company with only 1 post-clearance waiting period in a single foreign jurisdiction, though the region was not specified. Pfizer also announced that Brazil has given the merger the thumbs up. “We are...
Source: Mass Device - August 27, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Hospira Inc. Pfizer Inc. Source Type: news